Correlation of ageing with Health related-quality of life of patients in 13 groups of disease in Poland Authors: Marlena Krawczyk – Suszek, Arkadiusz Gaweł, Andrzej Kleinrok Published: 2024 ABSTRACT Background Age is a non-modifiable risk factor important in the etiology of many diseases. The ageing process of the body absolutely contributes to the degeneration of body tissues and the loss of function and the associated health-related quality of life (HR–QoL). Purpose Effect of age on HR–QoL among patients of 13 disease units. Matherial and methods The study was conducted among 7620 patients. The following age groups were included in the analysis: <30 years old, 30–39 years old, 40–49 years old, 50–59 years, 60–69 years, 70–79 years, and ≥ 80 years. The criterion for inclusion in the group was: age ≥ 18 years, written consent to participate in the study, treatment for chronic disease (at least 2 years), absence of other diseases and/or coexisting chronic symptoms. The SF-36 (Physical Component Summary (PCS); Mental Component Summary (MCS); Index of Life Quality (ILQ)) questionnaire was used to assess HR-QoL. Results The chance of having a better HR–QoL at 60–69 years of age decreases 3-fold (OR = 0.33) in MCS compared to the youngest group of patients. As far as PCS is concerned, there is a 5-fold lower chance of better HR–QoL (OR = 0.20). However, in the oldest group of patients, the chance of better HR–QoL in the MCS dimension is more than 12 times lower, and in PCS the chance of better HR–QoL is 33 times lower. A significant correlation between quality of life and age was confirmed. The level of PCS (R=-0.60), MCS (R=-0.50) and ILQ (R=-0.58) decreases with age. Cancer diseases (CD), regardless of the patient’s age, showed the strongest association with HRQoL among the 13 analyzed disease entities. The average level of HRQoL was the lowest. A decreased level of HRQoL was noted in patients with cardiovascular disease (CVD) aged 30–39 years. The highest HR–QoL was noted in the group of patients aged 40–49 years for both CD and CVD, in later years HR–QoL decreased in patients with CD and CVD. The chance of better HR–QoL decreases with age. After the age of 60, the highest decrease in HR–QoL is observed in both MCS and PCS. In all age groups, there is more often a chance of better HR–QoL in the MCS dimension than in PCS.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-024-78253-1. Introduction Quality of life (QoL) has been defined by the World Health Organization (WHO) as “a broad concept that is complexly influenced by physical health, mental state, level of independence, social relationships and its relationship to relevant environmental characteristics“1. However, the level of QoL is largely determined by existing diseases. They constitute a disturbance of the physical functioning of the human body, affecting other spheres such as psychological, social or spiritual. Then the level of QoL related to health is assessed – Health Related-Quality of Life (HR–QoL). Functional, medical, mental and individual limitations of the ability to cope with the disease, as well as functioning with dysfunctions, are conditioned by the feeling of HR – QoL. Thus, HR–QoL can be considered as one of the most important predictors of health care and an acceptable and important method of assessing the impact of the disease on daily functioning in the environment, activity and well-being of patients2. WHO reports that almost 18 million people died from CVDs in 2019, accounting for about 30% of all deaths3,4. CVD continues to dominate mortality and morbidity rates worldwide. There is also a high mortality in the group of cancer patients (about 10.0 million) and another 250 million patients are people with disabilities and reduced HR-QoL due to the disease5. On the other hand, there is an increasing incidence of diseases related to the development of civilization and new technologies in society, also in younger age groups. Disability associated with dysfunctions of the musculoskeletal system, especially the spine. Age is a non-modifiable factor for many diseases, including cardiovascular diseases, some types of cancer, and others. Scientific reports describing groups of patients with specific disease units indicate a significant decrease in HR–QoL with age6. The constant development of technology and civilization leads to the development of medicine, the emergence of new therapeutic and diagnostic techniques, early detection of diseases and better treatment effects, which has contributed to a dramatic increase in life expectancy in the last century7. Prolongation of life years is inevitably associated with the progressive process of old age. At this stage of life, physiological, irreversible changes occur in each of the human systems, which in turn leads to the appearance of cardiovascular diseases, skeletal and muscular disorders, arthritis, neurodegenerative diseases or cancer8. The appearance of physiological dysfunctions determines subsequent dysfunctions and disparities in the performance of social roles, but also economic problems for States9. According to the Global Burden of Disease study in 2017, out of 293 analysed disease units, as many as 92 were closely related to age10. This group included cardiovascular diseases, age-related neurodegenerative diseases, cancers and metabolic diseases. The appearance of diseases, especially chronic diseases, often significantly changes the life of the patient, and often also his/her family. This condition forces HR–QoL analysis, especially if we introduce new therapeutic solutions in the treatment of patients. The assessment of the quality of life often also helps in learning which aspects of the quality of life need improvement and support. An extensive study was conducted indicating the ranking of diseases determining HR–QoL in patients with 13 different disease units11. Conducting an extensive analysis, large differences in HR–QoL were noted due to the age of patients and its impact on individual spheres and dimensions of HR–QoL. As a result of these verifications, an attempt was made to present detailed analyses of age and its impact on HR–QoL among patients. Materials and methods Organization of the study The study was conducted randomly in primary health care clinics and in specialist clinics in hospitals. Before the study began, consent was obtained from medical facilities to conduct the study. 8,967 patients were examined. Missing data and incorrectly completed questionnaires were removed from the database. After removing the data gaps and incorrectly filled in data, a stratified sampling was carried out to ensure the representativeness of the age groups included in the study: <30 years old, 30–39 years old, 40–49 years old, 50–59 years, 60–69 years, 70–79 years, and ≥ 80 years. Patients from 13 disease units were included in the study: CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmological diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. After the use of a randomization frame, 7,620 patients with 13 different disease units were included in the actual study. The algorithm for determining the minimum sample size with a margin of error (e) of 0.05 for a population of 36 million people in Poland is a minimum of n = 384 samples. The included group of patients (the sample) in the study ensures representativeness. Before starting the study, the subjects were informed about the purpose, course and anonymity of the study and about the possibility of resigning from participation in the study at every stage of its duration. Before starting the study, the patient had to give informed, voluntary consent to participate in the study in written or electronic form. The study showed no signs of risk for the subject. The criterion for inclusion in the group was: age ≥ 18 years, written consent to participate in the study, treatment for chronic disease (at least 2 years), absence of other diseases and/or coexisting chronic symptoms. A positive opinion was obtained from the Commission on Ethics of Scientific Research (2/2022). The study was conducted in accordance with the Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects12. Study group The actual study included 7,620 patients. Maintaining the main purpose of the analyses, stratified selection was used to separate individual age groups created for further comparative analyses. The individual stages of the selection of the study group are presented by Flowchart. (Fig. 1) The exact characteristics of the study group, considering factors (gender, place of residence and level of education) are presented in Table 1. The group of the subjects reflects the demography of Poland in each of the analysed age groups. Fig. 1Flowchart of the participants selection process. Flowchart of the participants selection process. Table 1General characteristics of the study group of the respondents.CharacteristicsAge group[n;%]Total[7620; 100,0]< 30[728; 9,6]30–39[987; 12,9]40–49[1669; 21,9]50–59[1662; 21,8]60–69[1583; 20,8]70–79[803; 10,5]≥ 80[188; 2,5] n % n % n % n % n % n % n % n %Gender:female / male441/28760,6/39,4626/36163,4/36,6927/74255,5/44,5920/74255,4/44,6778/80549,1/50,9411/39251,2/48,8100/8853,2/46,84203/341755,2/44,8Place of residencecity/village533/19573,2/26,8661/32667,0/33,01012/65760,6/39,4972/69058,5/41,5891/69256,3/43,7489/31460,9/39,190/9847,9/52,14648/297261,0/39,0Education:higher / secondary / elementary408/ 301/1956,0/41,3/2,6662/313/1267,1/31,7/1,2817/746/10649,0/44,7/6,4607/841/21436,5/50,6/12,9348/904/33022,0/57,1/20,8124/401/28215,4/49,9/34,634/83/7118,1/44,1/37,83000/3589/103139,4/47,1/13,5n - number of observations; % - percent. Table 1General characteristics of the study group of the respondents.CharacteristicsAge group[n;%]Total[7620; 100,0]< 30[728; 9,6]30–39[987; 12,9]40–49[1669; 21,9]50–59[1662; 21,8]60–69[1583; 20,8]70–79[803; 10,5]≥ 80[188; 2,5] n % n % n % n % n % n % n % n %Gender:female / male441/28760,6/39,4626/36163,4/36,6927/74255,5/44,5920/74255,4/44,6778/80549,1/50,9411/39251,2/48,8100/8853,2/46,84203/341755,2/44,8Place of residencecity/village533/19573,2/26,8661/32667,0/33,01012/65760,6/39,4972/69058,5/41,5891/69256,3/43,7489/31460,9/39,190/9847,9/52,14648/297261,0/39,0Education:higher / secondary / elementary408/ 301/1956,0/41,3/2,6662/313/1267,1/31,7/1,2817/746/10649,0/44,7/6,4607/841/21436,5/50,6/12,9348/904/33022,0/57,1/20,8124/401/28215,4/49,9/34,634/83/7118,1/44,1/37,83000/3589/103139,4/47,1/13,5n - number of observations; % - percent. General characteristics of the study group of the respondents. Gender: female / male 441/ 287 60,6/ 39,4 626/ 361 63,4/ 36,6 927/ 742 55,5/ 44,5 920/ 742 55,4/ 44,6 778/ 805 49,1/ 50,9 411/ 392 51,2/ 48,8 100/ 88 53,2/ 46,8 4203/ 3417 55,2/ 44,8 Place of residence city/ village 533/ 195 73,2/ 26,8 661/ 326 67,0/ 33,0 1012/ 657 60,6/ 39,4 972/ 690 58,5/ 41,5 891/ 692 56,3/ 43,7 489/ 314 60,9/ 39,1 90/ 98 47,9/ 52,1 4648/ 2972 61,0/ 39,0 Education: higher / secondary / elementary 408/ 301/ 19 56,0/ 41,3/ 2,6 662/ 313/ 12 67,1/ 31,7/ 1,2 817/ 746/ 106 49,0/ 44,7/ 6,4 607/ 841/ 214 36,5/ 50,6/ 12,9 348/ 904/ 330 22,0/ 57,1/ 20,8 124/ 401/ 282 15,4/ 49,9/ 34,6 34/ 83/ 71 18,1/ 44,1/ 37,8 3000/ 3589/ 1031 39,4/ 47,1/ 13,5 n - number of observations; % - percent. Questionnaire SF-36 and sociodemographic factors The SF-36 questionnaire was used to assess the quality of life in the group of patients. The license to use the tool was obtained (License Number: QM039882). The raw data was encoded according to the tool key13,14. The raw results were converted to percentages [%]. The SF-36 survey questionnaire allows for the assessment of QoL in the following 8 areas: physical functioning - PF; role physical - RP; bodily pain - BP; general health - GH; vitality - VT; social functioning - SF; emotional roles - RE; mental health - MH. Individual spheres were assigned to two of the main dimensions. According to the tool key, individual spheres are assigned to two dimensions as follows: PF + RP + BP + GH are assigned to the Physical Component Summary (PCS) and VT + SF + RE + MH are assigned to the Mental Component Summary (MCS). PCS and MCS, constitute the Index of Life Quality (ILQ)14. Statistical analysis The main variable determining the direction of the analyses were age groups. It was assessed how age affected the perception of the disease in various spheres and dimensions of QoL assessed using the SF-36 questionnaire. Qualitative variables were presented using the number of observations and percentage. Variables measurable by mean, standard deviation and 95% confidence intervals. Using the W Shapiro Wilk test, the assumptions about the normality of the distribution of measurable variables were checked. For the analysis of two independent variables, the Z test was used, for more than two groups, the F test (ANOVA). Logistic regression was performed and the odds ratio of the occurrence of better HR – QoL among the patients from different age groups was assessed. Hierarchical clustering is a widely utilized clustering technique in data analysis and machine learning. It involves organizing data into a hierarchical tree or dendrogram structure. The primary aim of this technique is to group similar objects into clusters that share common characteristics or properties. The fundamental assumptions of hierarchical clustering include starting with single clusters, where the algorithm initiates by considering each object as an individual cluster. During the algorithm’s operation, a measure of similarity or distance between objects must be chosen, with the value of this measure determining which objects will be connected to form clusters. The algorithm iteratively merges the two most similar clusters into one and subsequently updates the similarity or distance matrix between the clusters. The process of combining clusters in pairs continues until a single main cluster encompassing all the data is formed, resulting in a dendrogram. The number of clusters was selected using two methods: scree plot and silhouette plot. The linkage method was checked using the agglomeration coefficient. Ward method was selected after calculating the agglomeration coefficient value for various possible connections and based on the highest value of the value, the connection method was selected. The correlation coefficient between the individual spheres and dimensions of SF-36 and the age (measurable variable) of the examined patients was also analysed. The value of the correlation coefficient is [-1;1]. To assess the degree of dependence of the analysed two measurable variables, the following distribution was adopted: 0-0.3 – weak correlation; 0.3–0.5 – medium correlation; 0.5–0.7 – high correlation; 0.7–0.9 – very high correlation; 0.9-1 – almost complete correlation. The correlation coefficient sign indicates a positive correlation and a negative correlation, respectively. A positive correlation confirms that an increase in one variable means an increase in the other variable, while a negative correlation means an increase in one variable and a decrease in the other. The absolute value of the correlation coefficient allows to verify the strength of the relationship of the analysed measurable variables15. Result The mean values obtained in the MCS, PCS and ILQ dimensions differ in individual age groups. In each of the analysed age groups, the lowest HR-QoL was noted in patients with CD. In the youngest group of the subjects (< 30 years old), the highest mean value of HR–QoL in MCS was recorded in the group of patients with DSD-Th (80.6). In the group of people aged 30–39 years in patients with DM (80.6). In people aged 40–49, the highest mean HR–QoL was recorded in patients with LD (80.1), similarly in the age group 50–59 (79.5), 60–69 years (75.8). Among people aged 70–79 years, the highest average HR–QoL was recorded in the patients with DSD–LS (60.5). In the group of the oldest subjects, the best mean HR–QoL was recorded in the DSD–Th patients (51.0). The worst HR–QoL was most often recorded in the oldest group of patients, with the exception of patients with NS, among whom the lowest HR–QoL was indicated by patients aged 70–79 (26.9%). (Fig. 2) Fig. 2Average value of MCS including age groups [percentage values]. MCS – Mental Component Summary; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. Average value of MCS including age groups [percentage values]. MCS – Mental Component Summary; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. As in the case of the MCS dimension, in the HR–QoL analysis in the PCS dimension, the lowest average quality of life was recorded in patients with CD. The highest mean HR–QoL among the youngest group was recorded in the patients with DSD-LS (82.7), in the group of 30–39 years in the patients with DM (76.7), in the group of 40–49 years in the patients with UD (69.8), in the group of 50–59 years in patients with LD (69.4), in the group of 60–69 years in the patients with LD (65.2), in the group of 70–79 years in the patients with DSD-LS (49.7), and in the oldest group in the patients with LD (42.9). The worst HR–QoL was most often recorded, as in the case of MCS, among the oldest study group, except for the patients with ED, where the lowest HR–QoL was indicated by people aged 70–79 (33.7%). (Fig. 3) Fig. 3Average value of PCS including age groups [percentage values]. PCS – Physical Component Summary; CD – canders; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. Average value of PCS including age groups [percentage values]. PCS – Physical Component Summary; CD – canders; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. The mean value of the overall HR–QoL (ILQ) is the lowest in each age group in the patients with CD. The highest mean HR–QoL among the youngest group was recorded in the patients with DSD-LS (80.7), in the group of 30–39 years in the patients with DM (78.7), in the group of 40–49 years in the patients with LD (74.8), in the group of 50–59 years in the patients with DSD-LS (63.7), in the group of 60–69 years in the patients with LD (74.5), in the group of 70–79 years in the patients with DSD-LS (55.1), and in the oldest group in the patients with DSD-Th (46.3). The worst HR–QoL in ILQ was indicated by the oldest respondents. (Fig. 4) Fig. 4Average value of ILQ including age groups [percentage values]. ILQ – Index of Life Quality; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. Average value of ILQ including age groups [percentage values]. ILQ – Index of Life Quality; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system. Table 2. summarizing MCS, PCS, ILQ presents age groups that similarly assessed their level of quality of life in individual dimensions without taking into account individual diseases. The values ​​given in parentheses indicate the percentage of people declaring a generally worse perceived HR – QoL (“0”). Two clusters were created in each dimension. In one of them, in both MCS, PCS and ILQ, there were respondents aged ≥ 70 who assessed the level of quality of life the worst. In the age group 60–69–53% of respondents indicated a worse level of quality of life in the MCS dimension, in the group 70–79 years – 66% indicated a worse level of quality of life, while in the oldest group 82% declared a worse level of quality of life. HR-QoL was assessed the best by the youngest respondents (27% indicated a worse level of HR-QoL) and with age the percentage of worse quality of life increased. Similarly, patients aged 30 to 49 years (29% respectively) assessed their HR-QoL. A similar data structure was obtained for PCS, but in this dimension, worse quality of life was more frequent in each age group compared to the MCS dimension. Detailed data are included in Table 2., and the analysis is supplemented by Table 1; Figs. 1 and 2 attached in the Appendix.Table 2 Overall impact of the disease on the feeling of a worse HR-QoL level (“0”) of patients from each age group. Agglomeration of age groups according to their negative impact on the level of quality of life in each years groups using the Ward method. [.] - percentage values ​​of worse quality of life HRQoL”0” [reference 0 to 1 mean 0–100%]; Ward method. Table 2 Overall impact of the disease on the feeling of a worse HR-QoL level (“0”) of patients from each age group. Agglomeration of age groups according to their negative impact on the level of quality of life in each years groups using the Ward method. [.] - percentage values ​​of worse quality of life HRQoL”0” [reference 0 to 1 mean 0–100%]; Ward method. Overall impact of the disease on the feeling of a worse HR-QoL level (“0”) of patients from each age group. Agglomeration of age groups according to their negative impact on the level of quality of life in each years groups using the Ward method. [.] - percentage values ​​of worse quality of life HRQoL”0” [reference 0 to 1 mean 0–100%]; Ward method. Table 3 Agglomeration of groups of diseases according to their negative impact on the level of quality of life in each years groups using the Ward method. * MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ – Index of Life Quality; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system; C -number of clusters; [.] - percentage values ​​of worse quality of life HRQoL”0”[reference 0 to 1 mean 0–100%]; Ward method. Table 3 Agglomeration of groups of diseases according to their negative impact on the level of quality of life in each years groups using the Ward method. * MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ – Index of Life Quality; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system; C -number of clusters; [.] - percentage values ​​of worse quality of life HRQoL”0”[reference 0 to 1 mean 0–100%]; Ward method. Agglomeration of groups of diseases according to their negative impact on the level of quality of life in each years groups using the Ward method. * MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ – Index of Life Quality; CD – cancers; CVD – cardiovascular disease; DM – diabetes mellitus; DS – disease of digestive system; DSD-C – degenerative changes of the cervical spine; DSD-LS – degenerative changes of the lumbosacral spine; DSD-Th – degenerative changes of the thoracic spine; ED – ophthalmic diseases; LD – ENT diseases; NS – diseases of the nervous system; RS – respiratory diseases; TD – thyroid diseases; UD – diseases of the kidneys and urinary system; C -number of clusters; [.] - percentage values ​​of worse quality of life HRQoL”0”[reference 0 to 1 mean 0–100%]; Ward method. Cluster structure in the age group < 30. The cluster structure in the dimensions of PCS, MCS, and ILQ in the age group below 30 years shows various groups of diseases related to quality of life. In the group of patients with cancers (CD) and digestive system diseases (DS), a decreased HRQoL is observed in the mental dimension (MCS: CD: 0.74, DS: 0.68), in the physical health area (PCS: CD: 0.70, DS: 0.53), and in overall quality of life (ILQ: CD: 0.74, DS: 0.63). For degenerative spinal changes (DSD) and ENT diseases (LD), the lowest frequency of poor HRQoL is recorded in all three categories, with values of “0” ranging from 0.02 to 0.07 for DSD and 0.09 for LD. Other diseases, such as diabetes (DM), ophthalmic diseases (ED), respiratory diseases (RS), and neurological disorders (NS), are included in the group of diseases that moderately correlate with quality of life in this age group, with mean values “0” ranging from 0.14 to 0.57. In the group of diseases that correlate most with reduced quality of life in the PCS dimension, alongside CD (0.70) and DS (0.53), NS (0.57) and ED (0.50) are also included. In summary, CD and DS most frequently demonstrate worse quality of life for young people in each dimension, while DSD and LD show the least correlation with HRQoL. The remaining diseases fall into the category of diseases that moderately correlate with HRQoL, indicating a diverse health status in this age group. The structure of clusters in the age group of 30–39 years shows that in the group of diseases associated with poorer mental quality of life (MCS), CD (0.70) and DS (0.47) are included, while the best quality of life is reported in DM (0.08) and DSD (0.09–0.23). In the case of PCS, the diseases that lower HRQoL include CD, CVD, and NS (each 0.67), while diseases reported to have good quality of life include DSD-LS (0.16), DSD-Th (0.06), DM (0.04), and LD (0.02). Overall quality of life (ILQ) is most negatively influenced by CD (0.67), CVD (0.67), and NS (0.58), while the lowest incidences of poor HRQoL are noted in DSD-Th (0.08), UD (0.05), and LD (0.02). CD, CVD, and NS determine the negative level of quality of life for individuals aged 30–39, as seen in all analyzed dimensions (MCS, PCS, ILQ). In this group, among patients with DSD and LD, poor HRQoL is least frequently reported, while other diseases such as DM, ED, and RS typically fall into the category of moderately debilitating HRQoL. The structure of clusters in the age group of 40–49 years shows that the group of diseases reducing HRQoL in the mental dimension (MCS) includes CD (0.59) and NS (0.42), while the lowest incidence of poor HRQoL is shown by LD (0.01) and UD (0.08). In the PCS dimension, RS (0.58), CD (0.60), and NS (0.71) belong to the group with the worst HRQoL, while the least poor HRQoL is observed in DM (0.20), DSD-Th (0.16), UD (0.08), and LD (0.04). The overall quality of life – Quality of Life Index (ILQ) is most diminished by RS (0.48), CD (0.62), and NS (0.65), whereas the best quality of life is recorded in DM (0.16), DSD-Th (0.17), LD (0.01), and UD (0.09). The cluster structure in the age group of 50–59 years shows that the diseases most strongly correlated with a reduced level of HR-QoL for mental health (MCS) are CD (0.67), NS (0.53), and RS (0.53), while the lowest level of HR-QoL is observed in LD (0.10), TD (0.19), and DSD-LS (0.21). In terms of physical health (PCS), the diseases correlated with reduced quality of life (HRQoL) include RS (0.68), CD (0.71), and NS (0.75), while diseases with a rare occurrence of poor HR-QoL are TD (0.23) and LD (0.07). Overall quality of life (ILQ) is most significantly lowered in disease groups RS (0.60), CD (0.68), and NS (0.76), while the lowest frequency of poor HR quality of life was observed in LD (0.08) and TD (0.19). In the disease groups CD, RS, and NS, a negative correlation with HR-QoL is recorded for the age group 50–59 years, which is evident across all analyzed parameters (MCS, PCS, ILQ). LD and TD are groups of diseases where better quality of life is observed, while other diseases such as CVD, DM, DS, and ED have a moderate impact. This may be due to the developed treatment methods for these diseases and the effectiveness of therapies that provide a better level of quality of life for patients. The cluster structure in the age group 60–69 years shows that the group of diseases with a high frequency of poor HR-QoL in the case of mental health (MCS) includes CD and NS (0.83, respectively), while the lowest frequency of poor HR-QoL was noted in the group of diseases: LD (0.1), TD (0.25). In the case of physical health (PCS), CD (0.88) and NS (0.91) are joined in this age group by digestive system diseases (DS: 0.85), in which a high frequency of poor HR-QoL was noted, while in LD (0.15) poor HR-QoL was rarely noted. The group of diseases with a high frequency of poor HR-QoL level related to quality of life (ILQ) included: CD (0.86) and NS (0.87) and RS (0.75), while the least common poor HR-QoL was noted in TD (0.3) and LD (0.13). CD and NS in almost every age group are included in the groups with a high frequency of poor HR-QoL, especially in the group of people aged 60–69, which is visible in all analyzed dimensions (MCS, PCS, ILQ). The cluster structure in the age group 70–79 years shows that in the case of neurological disorders (NS: 0.95), poor HR-QoL is definitely most frequently noted in the area of ​​mental health (MCS), while in TD (0), poor HR-QoL is not noted. The frequency of lower quality of life in the case of LD is higher compared to younger groups of patients. In the PCS dimension, the group of diseases where a high frequency of poor HR-QoL was noted are: TD (1.0), NS (0.97), DS (0.93) and CD (0.89), and the lowest frequency was recorded among: RS (0.57), DSD-Th (0.60). The quality of life (ILQ) is definitely reduced the most by TD (1.0) and NS (0.95), followed by the group of diseases that equally strongly reduce HRQoL: CD (0.82), CVD (0.76), ED (0.80), DS. (0.80), while the least common poor HR-QoL is noted in the group: DSD-Th: 0.53 and RS (0.52). In diseases such as NS and CD, the highest incidence of poor HRQoL is noted in people aged 70–79 years with a clear predominance of TD diseases, which in younger age groups belonged rather to the group with a low or medium impact on HRQoL. These relationships are visible in all analyzed parameters (MCS, PCS, ILQ). In DSD and LD, poor HR-QoL is noted very rarely, while in other diseases such as ED or UD, poor HR-QoL is noted more often. The cluster structure in the 80 + age group shows that the group in which poor HR-QoL was most frequently noted in the area of ​​mental health (MCS) includes the following diseases: ED (1.0), DS (1.0) and NS (1.0). All patients examined in this group indicated poorer quality of life. Subsequently, CVD (0.91) and CD (0.88), while poor quality of life was least frequently noted in the group of diseases: DSD-LS (0.33) and LD (0.5), DSD-Th (0.55) and UD (0.60). In the PCS dimension, poor HR-QoL was most frequently noted in: NS (1.0), DS (1.0), which also appeared in the MCS dimension, and DSD-LS (1.0), which indicates a 100% negative HR-QoL in the PCS sphere, with mental health being the least affected (0.33). The next group of diseases, where poor HR-QoL is most frequently noted are CD (0.96), CVD (0.96) and DM (0.95), and the least frequently noted in ED (0.67) and LD (0.67). 100% poor HR-QoL is noted in the overall quality of life (ILQ) in patients with ED, DS, NS and UD (1.0, respectively). The next group of diseases, where poor HR-QoL is most frequently noted in ILQ are: DM (0.87), CVD (0.91) and CD (0.92). The least frequently noted poor HR-QoL is in LD (0.5). Detailed analyses are presented in the Table 3.. Table 4Chance of better HR-QoL in MCS, PCS and ILQ dimensions, considering age groups.Age groupMCSPCSILQOR (+ Cl;-Cl)OR (+ Cl /-Cl)OR (+ Cl /-Cl)< 30***30–390,89 (0,71;1,10)0,78 (0,63;0,96)0,89 (0,72;1,10)40–490,88 (0,73;1,07)0,53 (0,44;0,64)0,68 (0,56;0,82)50–590,63 (0,52;0,76)0,40 (0,33;0,48) **0,53 (0,43;0,64)60–690,33 (0,27;0,40) **0,20 (0,16;0,24) **0,28 (0,23;0,34) **70–790,19 (0,15;0,24) **0,09 (0,07;0,11) **0,14 (0,11;0,17) **> 800,08 (0,05;0,12) **0,03 (0,02;0,06) **0,06 (0,04;0,09) **PCS – Physical Component Summary; MCS – Mental Component Summary; ILQ SF – 36 – Index of Life Quality; OR – Odds ratio; -95Cl/+95Cl – 95% confidence interaval; *- reference point; p - level of statistical significance Wald Chi2 test, logistic regression; ** - p < 0,001. Table 4Chance of better HR-QoL in MCS, PCS and ILQ dimensions, considering age groups.Age groupMCSPCSILQOR (+ Cl;-Cl)OR (+ Cl /-Cl)OR (+ Cl /-Cl)< 30***30–390,89 (0,71;1,10)0,78 (0,63;0,96)0,89 (0,72;1,10)40–490,88 (0,73;1,07)0,53 (0,44;0,64)0,68 (0,56;0,82)50–590,63 (0,52;0,76)0,40 (0,33;0,48) **0,53 (0,43;0,64)60–690,33 (0,27;0,40) **0,20 (0,16;0,24) **0,28 (0,23;0,34) **70–790,19 (0,15;0,24) **0,09 (0,07;0,11) **0,14 (0,11;0,17) **> 800,08 (0,05;0,12) **0,03 (0,02;0,06) **0,06 (0,04;0,09) **PCS – Physical Component Summary; MCS – Mental Component Summary; ILQ SF – 36 – Index of Life Quality; OR – Odds ratio; -95Cl/+95Cl – 95% confidence interaval; *- reference point; p - level of statistical significance Wald Chi2 test, logistic regression; ** - p < 0,001. Chance of better HR-QoL in MCS, PCS and ILQ dimensions, considering age groups. PCS – Physical Component Summary; MCS – Mental Component Summary; ILQ SF – 36 – Index of Life Quality; OR – Odds ratio; -95Cl/+95Cl – 95% confidence interaval; *- reference point; p - level of statistical significance Wald Chi2 test, logistic regression; ** - p < 0,001. The chances of a better HR–QoL in the SF–36 dimensions were assessed. The analysis confirmed a decrease in the chance of better HR–QoL with age. The reference value was the level of quality of life of the youngest patients. In each subsequent age group, HR–QoL decreases significantly. At the age of 60–69 years, the HR–QoL in MCS decreases 3-fold compared to the youngest group of patients (OR = 0.33). As far as PCS is concerned, there is a 5-fold lower chance of better HR–QoL (OR = 0.20). However, in the oldest group of patients, the chance of better HR–QoL in the MCS dimension is more than 12 times lower, and in PCS 33 – the chance of better HR–QoL is 33 times lower. (Table 4). The percentage of incidence of worse HR-QoL (0) in individual age groups and disease units was also assessed. Detailed analyses are presented in the Appendix (Figs. 3–16). Table 5Correlation coefficients between the SF-36 and age (quantitative variable).SpheresAge p PF -0,42< 0,001 RP -0,35< 0,001 BP -0,33< 0,001 GH -0,30< 0,001 VT -0,120,003 SF -0,25< 0,001 RE -0,28< 0,001 MH -0,04< 0,001 HCh -0,09< 0,001 PCS -0,60< 0,001 MCS -0,50< 0,001 ILQ -0,58< 0,001PF – physical functioning; RP – role physical; RE – role emotional; VT – vitality; MH – mental health; SF – social functioning; BP – bodily pain; GH – general health; HCh - subjective sense of change in health; MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ SF – 36 – Index of Life Quality; p - level of statistical significance Wald Chi2 test, logistic regression. Table 5Correlation coefficients between the SF-36 and age (quantitative variable).SpheresAge p PF -0,42< 0,001 RP -0,35< 0,001 BP -0,33< 0,001 GH -0,30< 0,001 VT -0,120,003 SF -0,25< 0,001 RE -0,28< 0,001 MH -0,04< 0,001 HCh -0,09< 0,001 PCS -0,60< 0,001 MCS -0,50< 0,001 ILQ -0,58< 0,001PF – physical functioning; RP – role physical; RE – role emotional; VT – vitality; MH – mental health; SF – social functioning; BP – bodily pain; GH – general health; HCh - subjective sense of change in health; MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ SF – 36 – Index of Life Quality; p - level of statistical significance Wald Chi2 test, logistic regression. Correlation coefficients between the SF-36 and age (quantitative variable). PF – physical functioning; RP – role physical; RE – role emotional; VT – vitality; MH – mental health; SF – social functioning; BP – bodily pain; GH – general health; HCh - subjective sense of change in health; MCS – Mental Component Summary; PCS – Physical Component Summary; ILQ SF – 36 – Index of Life Quality; p - level of statistical significance Wald Chi2 test, logistic regression. The correlation of age as a quantitative variable with the results from individual scales and dimensions of SF–36 was assessed. The strongest negative correlations were marked for the dimension: PCS (-0.60), MCS (-0.50) and ILQ (-0.58). This means that with age, the level of perceived quality of life in each of the spheres and dimensions significantly decreases. (Table 5) For detailed analyses, see Appendix (Figs. 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 and 31). Discussion Health – Related Quality of Life is a factor that should be constantly monitored and analysed, due to the progress of solutions in the field of medicine, diagnostics and therapy. At the same time, the assessment of the quality of life is not an easy factor to verify. The sense of quality of life at any point in life may be influenced by various factors, such as obesity16depression, which also often coexists with obesity17individual diseases, the analysis of which can be found in the literature18–21, or emerging pandemics, such as COVID – 1922,23, which affect not only the sick but also the healthy population of countries14. For this reason, the quality of life is an inexhaustible area of research and analysis, especially when new factors destabilizing a person or entire groups of communities appear, in the physical and mental spheres. The presented study results are extensive studies covering 13 different disease units and an attempt to assess HR–QoL considering age groups. Studies available in the literature focusing on the analysis of specific disease units and groups of people show that with age there is a decrease in HR–QoL. A significant decrease in HR–QoL is recorded in people over 55 years of age, especially in the physical dimension. On average, values were obtained in the PCS dimension – 40.0%, while in the MCS dimension – 40.3%6. Epidemiological statistics indicate that CVD are the most frequently recorded diseases in Poland and in the world, emphasizing the high rate of morbidity, morbidity and mortality. Studies also confirm that regardless of the region, the occurrence of CVD significantly reduces HR–QoL24,25. Decreased HR–QoL is amplified in the patients with CVD in old age, especially if the patient undergoes frequent hospitalizations. In this study, seniors rated HR–QoL in the PCS dimension at 50.14%, and MCS: 52.71%26. In the author’s studies, an unsatisfactory level of HR–QoL was recorded in the group of people aged 30–39. They rate HR–QoL worse compared to the older group of patients aged 40–49 years. It is concluded that a much lower level of quality of life is due to young age, greater ambition, opportunities for development and significant limitations associated with the disease. In subsequent age groups ≥ 50 years, the quality of life gradually decreases. Thus, the highest level of HR–QoL among all analysed age groups was recorded in people aged 40–49. Both MCS and PCS rated their HR–QoL best. Cancer occupies the next place in the triad of mortality. Among all analysed disease units, the lowest level of HR–QoL was recorded in this group of patients regardless of age. Studies available in the literature confirm that the quality of life of cancer patients is very low27. The assessment of the quality of life in this group of patients is a valuable source of information not only in the area of symptoms, side effects of treatment, but also information on how the assessment of social life and mental health of these patients is shaped. One study indicated that only 30% of cancer patients are able to perform normal activities of daily living. The biggest problems occurred with self-care (81%, 95% CI: 76–89) and feelings of anxiety and depression (63%, 95% CI: 60–68)28. In the author’s studies, HR–QoL did not exceed 50% in any of the age groups. This is confirmed by the very low level of HR–QoL. The best quality of life among all age groups in each of the MCS and PCS dimensions was demonstrated by the patients aged 40–49 years. The quality of life in this group of patients is low in every dimension. It is estimated that complications after cancer treatment, related to both a deterioration in physical well-being, as well as fears and anxiety related to the disease, effectiveness and success of treatment, lower the sense of quality of life in these dimensions. In the role of clusters, it was shown that CD strongly worsens ILQ in the age groups ≥ 80 (0.92), 60–69 (0.86) and 70–79 (0.82). It is confirmed that in the group of patients with DM, the perception of HR–QoL is influenced by many sociodemographic factors such as gender, age, level of education, especially basic or secondary education, or lower economic status29–32. In the case of the analysis of age groups, the greatest differences were noted in the 55–65 age group and in the elderly. From the age of 55, the patients with DM indicated greater problems related to the disease, such restrictions in normal activities, the appearance of anxiety and depressive states. This condition significantly reduced the quality of life assessed on the EQ VAS scale (≤ 54.9)29. Our own studies have confirmed that in patients with DM aged ≥ 60 years, an unsatisfactory level of HR-QoL is noted, which increases with age. In younger patients, the perceived level of HR-QoL is higher. The earlier diabetes is diagnosed and effective treatment is implemented, the patient’s quality of life remains at a relatively high level for a long time. Diabetes up to the age of 80 is in the group of diseases which have a moderately negative impact on HRQoL. Studies evaluating HR–QoL in the patients with lower back pain did not show significant correlations with MCS and PCS in some studies. Only significant correlations in the MCS dimension were shown in the case of chronic pain33. In the author’s studies, HR–QoL of the patients with degenerative changes of each of the spine sections (C, Th, LS) was assessed. In patients over 49 years of age, HR–QoL was better assessed in the PCS dimension, while the MCS dimension was worse. Such a distribution of results was noted in degenerative changes of the C, Th and LS spine. Among younger respondents, degenerative changes in the spine more often reduced the quality of life in the MCS dimension. An example is the poorer quality of life in the mental dimension in people aged 30–39 compared to the physical dimension (PCS = 0.21). Hence, the conclusion is that HR-QoL decreased with age and at a later age, lower HRQoL was noted in the PCS sphere in this group of patients. Degenerative changes in the musculoskeletal system are inevitable. They deepen with age and intensify a number of consequences of these changes, especially in the area of ​​neurology, significantly hindering or completely preventing the performance of daily activities, lowering the sense of physical and mental health due to numerous limitations and disabilities. For many years, studies have been conducted on the quality of life of the patients with neurological disorders34. On the other hand, one of the most important factors correlating with age is the physiological ageing of the body, systems, including vessels, which may contribute to weakness and susceptibility to threats and the appearance of neurological disorders35,36. A strong correlation of age is noted in the case of neurodegenerative dementia37. The emergence of chronic neurological disorders lowers HR–QoL. In the study group, the average HR–QoL level did not exceed 60%. This highest average value was indicated by the youngest study group in the MCS dimension. The PCS dimension was assessed worse in each age group compared to the MCS dimension. A high prevalence of poor HR-QoL was noted in the neurological disease group in patients aged 60 years and older. On average, over 80% of the study participants, and in the oldest groups 100% of the study participants, indicated a decrease in the perceived HR-QoL in both the MCS and PCS dimensions. These data are confirmed by cluster analysis showing values ​​for ILQ ≥ 0.87 in patients ≥ 60 years of age. It is concluded that the aging process of the body strongly increases the destructive processes in the body, which is why in old age neurological diseases in almost every patient determine a worse quality of life, both in the mental and physical sphere, despite advanced treatment methods. Dysfunctions and diseases related to the urinary tract also affect HR–QoL. The patients with chronic renal undergoing haemodialysis have a below-average HR–QoL, which is often associated with recurrent infections and swelling and the consequences of dialysis38. Psychological and biological changes associated with dialysis treatment increase the risk of developing depression, which occurs three to four times more often than in the general population, increasing the progression of kidney disease and even increasing the mortality rate39. Older age also significantly reduces the quality of life of the patients after haemodialysis40. In the author’s studies, the highest average HR–QoL among the patients with diseases of the kidneys and urinary system was recorded among the patients aged 30–39 years. After the age of 40, HR–QoL gradually decreased. In conclusion, it should be emphasized that HR–QoL includes many factors that should be constantly analysed and monitored to improve the quality of life of the patients, support the patient and family often in difficult times of illness and the recovery process in which medical procedures are carried out. Age is only a small element in the analysis of quality of life41, although it is very important and generates strong dependencies and deterioration of the overall perceived HR–QoL. A holistic approach to the patient and their families is a unique approach that has been emphasized in medical and health sciences as the best and most effective for many years. However, a holistic approach to the patient can be said when factors that reduce the patient’s quality of life are known. Then a whole spectrum of activities of various nature can be undertaken to actively support the patient during and after treatment. Apart from the significant impact of cancer diseases on the reduction of the HR-QoL level, attention should be paid to neurological diseases, which significantly or even completely reduced the sense of quality of life in each of the studied patients in old age, both in the mental and physical sphere. Hence, neurological diseases, in addition to cancer diseases, circulatory system diseases, should be an equally important factor in the analysis of quality of life, especially in seniors. In younger groups, NS are usually included in the group of diseases with a moderate impact on the reduction of HR-QoL. Limitation The studies involve certain limitations. Including all factors in the analysis and at the same time excluding those that may significantly disturb the analysed HR–QoL level is very difficult to achieve. The analysis of 13 disease units is an extensive study. One focuses exclusively on the exclusion of other disease units in the patients included in the study. The presented analyses did not analyse the impact of socio-economic status or education level, which will be another factor in the authors’ analyses, and may be an element limiting the assessment of the level of perceived HR–QoL. The lack of people with CVD under the age of 30 may be a limitation of the study. However, it is a phenomenon commonly present in the general population. The risk of CVD in such a young age group is very low. The HR-QoL study was conducted using only the SF-36 questionnaire, which is a standardized and commonly used tool, but may miss other important factors determining HR-QoL. However, when assessing quality of life in 13 different disease entities, it is not possible to use questionnaires dedicated to specific groups of patients with given disease entities, because it would not be possible to compare the quality of life of these patients. There would be a high risk that each questionnaire dedicated to other disease entities would examine different aspects of quality of life that are important for a given group of patients, causing a lack of possibility of comparisons between these groups. The reliability analysis of the tool used for the study was conducted. The Cronbach’s alpha values ranging from 0.83 to 0.92 indicate a good fit of the tool (Table no 2 and 3 in Appendix). Conclusion Cancers, regardless of the patient’s age, reduce HRQoL the most among the 13 analysed disease units. CVD significantly reduced the quality of life among people aged 30–39. The highest HR–QoL was recorded in the group of patients aged 40–49 years for both CD and CVD, in later years HR–QoL decreased in patients with CD and CVD. The chance of better HR–QoL decreases with age. After the age of 60, the highest decrease in HR–QoL is observed in both MCS and PCS. In all age groups, there is more often a chance of better HR–QoL in the MCS dimension than in PCS. At the age of 60+, all patients with NS have a worse perceived level of HR-QoL in both dimensions (PCS, MCS). In addition to CD, CVD, HR-QoL should be assessed in patients with neurological diseases (NS), especially among seniors. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1